Literature DB >> 32601623

Consequences of the COVID-19 Pandemic on Cancer Clinical Trials.

Sally Flores1, Nita Kurian1, Anu Yohannan1, Christina Persaud1, Muhammad Wasif Saif1.   

Abstract

The battle against cancer is formidable even in normal circumstances and the COVID-19 selectively cancer patients with an increased risk of mortality by three times higher than those without cancer but also forced us to shut down the clinical trials in cancer patients to deal with the present crisis. We discuss here the disruptions on research in cancer with its immediate and delayed consequences and offer some suggestions to modify our practices, strategies and rationalization to help succeed the cancer treatment and research after the crisis is over.

Entities:  

Keywords:  COVID-19; Cancer; Clinical trial, Chemotherapy; Research

Year:  2020        PMID： 32601623      PMCID： PMC7324032     

Source DB:  PubMed          Journal:  Cancer Med J


  6 in total

1.  Our challenge is to adapt the organization of our system to the six stages of the epidemic to go beyond the COVID-19 crisis.

Authors:  J J Tuech; A Gangloff; L Schwarz
Journal:  Br J Surg       Date:  2020-04-30       Impact factor: 6.939

2.  COVID-19 and Cancer Patients.

Authors:  Rajvi Patel; Jennifer Park; Ankit Shah; Muhammad Wasif Saif
Journal:  Cancer Med J       Date:  2020-04-03

3.  Cancer at the time of the COVID-19 hurricane.

Authors:  Giovanni Blandino
Journal:  J Exp Clin Cancer Res       Date:  2020-04-29

4.  Effect of the COVID-19 Pandemic on Cancer Clinician Decision Making: Known Knowns and Known Unknowns.

Authors:  I S Boon; T P T Au Yong; C S Boon
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-04-25       Impact factor: 4.126

5.  Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities.

Authors:  Ronaldo Elkaddoum; Fady Gh Haddad; Roland Eid; Hampig Raphael Kourie
Journal:  Future Oncol       Date:  2020-05-01       Impact factor: 3.404

6.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.

Authors:  Wenhua Liang; Weijie Guan; Ruchong Chen; Wei Wang; Jianfu Li; Ke Xu; Caichen Li; Qing Ai; Weixiang Lu; Hengrui Liang; Shiyue Li; Jianxing He
Journal:  Lancet Oncol       Date:  2020-02-14       Impact factor: 41.316
  6 in total
  4 in total

1.  Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic?

Authors:  Matthew I Ehrlich; M Wasif Saif
Journal:  Arch Cancer Biol Ther       Date:  2020

Review 2.  Impact of the COVID-19 Pandemic on Cancer Researchers in 2020: A Qualitative Study of Events to Inform Mitigation Strategies.

Authors:  Louis Fox; Katharina Beyer; Elke Rammant; Esme Morcom; Mieke Van Hemelrijck; Richard Sullivan; Verna Vanderpuye; Dorothy Lombe; Audrey Tieko Tsunoda; Tezer Kutluk; Nirmala Bhoo-Pathy; Shanmugham C Pramesh; Aasim Yusuf; Christopher M Booth; Omar Shamieh; Sabine Siesling; Deborah Mukherji
Journal:  Front Public Health       Date:  2021-11-24

3.  Understanding the experiences of patients with cancers in hospitals during COVID-19 pandemic in China: A qualitative research study.

Authors:  Xing Chen; Wenyu Deng; Wenjuan Zhou; Ying Liu; Jinfeng Chen; Yuan Gao; Kuirong Xiao; Lin Man; Wanting Qu; Hongjuan Zeng; Sha Ye
Journal:  Nurs Open       Date:  2021-09-26

4.  Impact of COVID-19 Pandemic Declaration on New Oncology Trial Commencements: An Interrupted Time Series with Segmented Regression Analysis.

Authors:  Hyeon Uk Bin; Sohyun Jeong; Heeyoung Lee
Journal:  Healthcare (Basel)       Date:  2022-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.